HURA TuHURA Biosciences, Inc.: Bozor kapitallashuvining balans qiymatiga nisbati
TuHURA Biosciences, Inc. (HURA) onkologiyaning ilg'or davolash usullarini ishlab chiqishga ixtisoslashgan. Ushbu narxlar grafigi aktivning bozor dinamikasini aks ettiradi va uning ko'rsatkichi hozirda 7.09 darajasida. Biznes dori ishlab chiqarishni US dagi CDMO hamkorlari orqali autsorsing qilishga tayanadi, o'sish strategiyasi esa yirik investorlar qo'llab-quvvatlagan holda innovatsion vaksinalarni joriy etish va dori vositalariga nisbatan chidamlilikni yengishga asoslangan.
%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_HURA_-_TuHURA-Biosciences-Inc._-_Market-Cap-to-Net-Assets-Ratio "TuHURA Biosciences, Inc. (HURA) Bozor kapitallashuvining balans qiymatiga nisbati: 04.07.2022 - 30.10.2026 davri uchun | 👁️GURU.Markets👁️")
TuHURA Biosciences, Inc. (HURA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati TuHURA Biosciences, Inc.|HURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati tuhurabio.com|HURA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati TuHURA|HURA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari TuHURA Biosciences|Tezkor likvidlik koeffitsiyenti tuhurabio.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:TuHURA Biosciences, Inc.
Ushbu ko'rsatkich aksiyalarning joriy bozor qiymatini kompaniyaning sof aktivlari bilan solishtirib, kotirovkalarning real kapitalga nisbatan premium yoki diskont darajasini aniqlaydi. Erta klinik sinovlar uchun tashqi moliyalashtirishga tayanadigan TuHURA Biosciences, Inc. (HURA) uchun bozor qiymatining kitob kapitaliga nisbati, yuqori likvidlik bo'shlig'i xavfi fonida spekulyativ aktivlarning haddan tashqari qimmat baholanishining muhim belgisi bo'lib xizmat qiladi.
TuHURA Biosciences, Inc. kimlar bilan raqobatlashadi
ONC: Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga nisbati|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bozor qiymatining balans qiymatiga nisbati Bicara Therapeutics Inc. BCAX|PSNL: Kapitallashuvning balans qiymatiga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Delcath Systems Inc (DCTH) - Kapitallashuvning sof aktivlarga nisbati|YMAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aura Corp (AURA)|Bozor qiymatining balans qiymatiga nisbati Candel Therapeutics Inc.|ARAY: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CTOR (Citius Oncology, Inc)|TARA - Kapitallashuvning sof aktivlarga nisbati|FATE: Kapitallashuvning sof aktivlarga nisbati|WHWK - Bozor kapitallashuvining balans qiymatiga nisbati|tscan.com (TCRX) - Bozor qiymatining balans qiymatiga nisbati|Champions Oncology, Inc. - Balans qiymatiga nisbatan bozor qiymati|XBIT (XBiotech Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp CVM|Kapitallashuvning sof aktivlarga nisbati OSTX (OS Therapies Incorporated)|Bozor kapitallashuvining balans qiymatiga multiplikatori RADX|Artiva Biotherapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Adlai Nortye Ltd ANL|Veru Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati TPST (Tempest Therapeutics Corp)|XLO (xiliotx.com) - Kapitallashuvning sof aktivlarga nisbati|Renovaro (RENB) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Mural Oncology PLC|KAPA: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati OKUR|Bozor kapitallashuvining balans qiymatiga nisbati w2.cytomed.sg (GDTC)|Curis - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati APLM|Tharimmune - Bozor kapitallashuvining balans qiymatiga nisbati|ADVB: Bozor qiymatining balans qiymatiga nisbati|GNPX: Bozor kapitallashuvining balans qiymatiga nisbati|CLDI - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Sunshine Biopharma|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenetic Bio XBIO|Bozor qiymatining balans qiymatiga nisbati Salarius Pharmaceuticals, Inc. (SLRX)|Balans qiymatiga nisbatan bozor kapitallashuvi Purple Biotech Ltd|Bozor kapitallashuvining balans qiymatiga nisbati AONC (American Oncology Network, Inc.)|BGNE - Kapitallashuvning sof aktivlarga nisbati|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Elevation Oncology Inc. ELEV|ICAD: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Ikena Oncology (IKNA)|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc.|Kapitallashuvning balans qiymatiga nisbati VIRX (Viracta)|Bozor kapitallashuvining balans qiymatiga nisbati MOR|Kapitallashuvning sof aktivlarga nisbati nayabiosciences.com NAYA|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)